GYRE THERAPEUTICS, INC.: directors' dealings · United States · SEC (Form 4) Explore the full management transaction log of GYRE THERAPEUTICS, INC., a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €594.8m. The latest transaction was reported on 27 May 2026 (Levée d'options). Among the most active insiders: Ma Songjiang. The full history is free.
€727,251
39 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 27 May 2026
All Executives50 Thresholds0 Prospectus0 Other0
Declarations 50 total
◇ Chief Operating Officer · Executives · 22 May 2026
3,500 shares @ US$0.75 0.8% of flow Common Stock SEC:0001140361-26-022980:0
▼ Chief Operating Officer · Executives · 22 May 2026
3,500 shares @ US$6.08 6.4% of flow Common Stock SEC:0001140361-26-022980:1
◇ Chief Operating Officer · Executives · 26 May 2026
4,000 shares @ US$0.75 0.9% of flow Common Stock SEC:0001140361-26-022980:2
▼ Chief Operating Officer · Executives · 26 May 2026
4,000 shares @ US$6.1001 7.3% of flow Common Stock SEC:0001140361-26-022980:3
▼ President · Executives · 20 May 2025
2,000 shares @ US$11.25 2.9% of flow Common Stock SEC:0001140361-25-020156:0
▼ President · Executives · 16 May 2025
2,000 shares @ US$11.31 2.9% of flow Common Stock SEC:0001140361-25-019893:0
▼ President · Executives · 14 May 2025
20 shares @ US$11.30 0.0% of flow Common Stock SEC:0001140361-25-019468:0
▼ President · Executives · 12 May 2025
2,000 shares @ US$10.56 2.8% of flow Common Stock SEC:0001140361-25-018927:0
◇ Chief Operating Officer · Executives · 1 Apr 2025
50,000 shares @ US$0.75 12.1% of flow Common Stock SEC:0001140361-25-019053:0
◇ Chief Operating Officer · Executives · 24 Mar 2025
300,000 shares @ US$0.75 72.5% of flow Common Stock SEC:0001140361-25-015712:0
◇ Director · Executives · 16 Apr 2025
15,000 shares @ US$6.93 100.0% of flow Common Stock SEC:0001140361-25-014601:0
▼ President · Executives · 21 Mar 2025
174 shares @ US$10.00 0.2% of flow Common Stock SEC:0001140361-25-010234:0
▼ President · Executives · 19 Mar 2025
2,000 shares @ US$10.13 2.7% of flow Common Stock SEC:0001140361-25-009877:0
▼ President · Executives · 17 Mar 2025
2,000 shares @ US$12.09 3.2% of flow Common Stock SEC:0001140361-25-009424:0
▼ President · Executives · 13 Mar 2025
2,000 shares @ US$11.80 3.2% of flow Common Stock SEC:0001140361-25-009017:0
▼ President · Executives · 11 Mar 2025
2,000 shares @ US$11.40 3.1% of flow Common Stock SEC:0001140361-25-008623:0
▼ President · Executives · 7 Mar 2025
53 shares @ US$13.03 0.1% of flow Common Stock SEC:0001140361-25-008091:0
▼ President · Executives · 5 Mar 2025
2,000 shares @ US$10.98 3.0% of flow Common Stock SEC:0001140361-25-007602:0
▼ President · Executives · 3 Mar 2025
2,000 shares @ US$11.23 3.1% of flow Common Stock SEC:0001140361-25-007173:0
▼ President · Executives · 27 Feb 2025
2,000 shares @ US$11.33 3.1% of flow Common Stock SEC:0001140361-25-006738:0
▼ President · Executives · 25 Feb 2025
2,000 shares @ US$11.37 3.2% of flow Common Stock SEC:0001140361-25-006273:0
▼ President · Executives · 21 Feb 2025
1,818 shares @ US$11.84 3.0% of flow Common Stock SEC:0001140361-25-005842:0
▼ President · Executives · 19 Feb 2025
2,000 shares @ US$12.29 3.4% of flow Common Stock SEC:0001140361-25-005420:0
▼ President · Executives · 14 Feb 2025
2,000 shares @ US$11.94 3.3% of flow Common Stock SEC:0001140361-25-005113:0
▼ President · Executives · 12 Feb 2025
2,000 shares @ US$11.49 3.2% of flow Common Stock SEC:0001140361-25-004744:0
25 of 50 declarations
Load more (25 remaining)